We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+2.75%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$27.5B
AUM Growth
+$4.26B
(+18%)
Cap. Flow
+$26B
Cap. Flow
% of AUM
94.62%
Top 10 Holdings %
Top 10 Hldgs %
8.07%
Holding
3,226
New
745
Increased
868
Reduced
662
Closed
894
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$221M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$206M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$192M |
| 4 |
NVIDIA
NVDA
|
+$183M |
| 5 |
Apple
AAPL
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$151M |
| 2 |
Johnson & Johnson
JNJ
|
+$149M |
| 3 |
ConocoPhillips
COP
|
+$142M |
| 4 |
Danaher
DHR
|
+$112M |
| 5 |
S&P Global
SPGI
|
+$106M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.09% |
| 2 | Consumer Discretionary | 14.55% |
| 3 | Financials | 12.04% |
| 4 | Healthcare | 11.32% |
| 5 | Industrials | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Instil Bio
TIL
$49.2M
| $57.5K | ﹤0.01% |
+5,214
| New | +$63.7K |
|
|
APPH
2052
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $57.1K | ﹤0.01% |
+154,191
| New | +$69.6K |
|
|
TGB
2053
Trekor Metals
TGB
$2.53B
| $57K | ﹤0.01% |
39,891
-65,172
| -62% | -$97.5K |
|
2054
Sportsman's Warehouse
SPWH
$44.5M
| $57K | ﹤0.01% |
+10,006
| New | +$60.2K |
|
|
HLTH
2055
DELISTED
Cue Health Inc. Common Stock
HLTH
| $56.7K | ﹤0.01% |
+153,787
| New | +$131K |
|
2056
Palladyne AI
PDYN
$238M
| $56.3K | ﹤0.01% |
+29,163
| New | +$69.6K |
|
|
EXPR
2057
DELISTED
Express, Inc.
EXPR
| $56.2K | ﹤0.01% |
+4,738
| New | +$68.8K |
|
2058
Atara Biotherapeutics
ATRA
$70.3M
| $56.2K | ﹤0.01% |
+1,396
| New | +$78.9K |
|
2059
VanEck BDC Income ETF
BIZD
$1.62B
| $55K | ﹤0.01% |
1,194
+772
| +183% | +$11.3K |
|
2060
Global X Social Media ETF
SOCL
$91.7M
| $54.7K | ﹤0.01% |
2,545
+2,494
| +4,890% | +$89.2K |
|
2061
Vanguard Value ETF
VTV
$190B
| $54.3K | ﹤0.01% |
+264
| New | +$36.7K |
|
2062
DHI Group
DHX
$175M
| $53.8K | ﹤0.01% |
14,058
-8,370
| -37% | -$31K |
|
|
TUP
2063
DELISTED
Tupperware Brands Corporation
TUP
| $53K | ﹤0.01% |
+66,245
| New | +$71.8K |
|
|
FINV
2064
FinVolution Group
FINV
$1.15B
| $52.9K | ﹤0.01% |
11,507
-22,243
| -66% | -$91.5K |
|
2065
State Street SPDR S&P Semiconductor ETF
XSD
$2.65B
| $52.5K | ﹤0.01% |
2,483
+916
| +58% | +$181K |
|
2066
iShares MSCI EAFE ETF
EFA
$76.9B
| $52.3K | ﹤0.01% |
910
-20,064
| -96% | -$1.46M |
|
|
AUTL
2067
Autolus Therapeutics
AUTL
$386M
| $52.1K | ﹤0.01% |
+21,907
| New | +$52K |
|
2068
Vanguard S&P 500 Growth ETF
VOOG
$25.3B
| $51.3K | ﹤0.01% |
3,474
-5,520
| -61% | -$219K |
|
2069
Mizuho Financial
MFG
$123B
| $51.2K | ﹤0.01% |
16,671
+5,517
| +49% | +$16.4K |
|
2070
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$68.4M
| $50.4K | ﹤0.01% |
+163
| New | +$24.3K |
|
2071
Hydrofarm Holdings
HYFM
$3.17M
| $50K | ﹤0.01% |
+6,400
| New | +$76.5K |
|
2072
Vanguard Russell 3000 ETF
VTHR
$4.65B
| $49K | ﹤0.01% |
708
+208
| +42% | +$38.9K |
|
|
CELL
2073
DELISTED
PhenomeX Inc. Common Stock
CELL
| $48.9K | ﹤0.01% |
+99,718
| New | +$81.6K |
|
2074
Celularity
CELU
$22M
| $47.6K | ﹤0.01% |
+8,928
| New | +$57.2K |
|
2075
iShares MSCI Brazil ETF
EWZ
$9.13B
| $47.1K | ﹤0.01% |
1,490
-26,846
| -95% | -$799K |
|
Similar funds
Qube Research & Technologies (QRT)'s Q2 2023 Portfolio in Review
As of Q2 2023, Qube Research & Technologies (QRT) held 3,226 positions worth $27.5B, up 18% from $23.2B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
Qube Research & Technologies (QRT) deployed $26B of net new capital in Q2 2023, opening 745 new positions and adding to 868 existing holdings. Its largest new stake was Microsoft: 704,526 shares worth $240M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Cigna, an estimated $151M trimmed.
- Qube Research & Technologies (QRT)'s largest Q2 2023 buy was Microsoft: 704,526 shares worth $240M.
- Qube Research & Technologies (QRT) added most to Thermo Fisher Scientific in Q2 2023, an estimated $192M increase.
- Qube Research & Technologies (QRT)'s biggest Q2 2023 reduction was Cigna, cutting an estimated $151M.
- Qube Research & Technologies (QRT) fully exited ConocoPhillips in Q2 2023, selling an estimated $142M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 8.1% of its $27.5B portfolio in Q2 2023.
- Qube Research & Technologies (QRT) opened 745 new positions and closed 894 in Q2 2023.
- Qube Research & Technologies (QRT)'s portfolio value rose 18% quarter-over-quarter to $27.5B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.